Patrick Campbell is the managing editor of HCPLive. Formerly the editorial lead of Endocrinology Network, Practical Cardiology, and Rheumatology Network, Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. He now helps to lead coverage in each of these respective areas for HCPLive. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.
Women with Common Endocrine Disorder at Increased Risk of Cardiovascular Disease Risk
June 13th 2021A recent review of data from within a major European-based database indicates women with PCOS were at a 26% greater risk of major adverse cardiovascular events when compared to matched controls without polycystic ovary syndrome.
Read More
Despite Awareness of Cardiovascular Risks, Many Smokers Continue Tobacco Use
June 10th 2021An analysis of survey responses from 2013-2018 indicates many patients with a history of cardiovascular disease who use tobacco continue to do so, despite being aware of the increased risk associated with smoking and tobacco use.
Read More
Women with Polycystic Ovary Syndrome at Increased Risk of Cardiovascular Disease Events
June 10th 2021A comparison of women with PCOS to matched controls indicates women with PCOS were at a 26% greater risk of experiencing major adverse cardiovascular events than their counterparts without polycystic ovary syndrome.
Read More
A Need for Change: Enhancing the Well-Being of Cardiology Professionals
June 10th 2021The third of 5 slideshows included in our "A Need for Change" series, details the work of Task Force 3 from the American Heart Association/American College of Cardiology Consensus Conference on Professionalism and Ethics, which sought to identify shortcomings and avenues for improving the well-being of cardiologists and cardiology professionals.
Read More
Evaluating Subsequent Fracture Risk in Aging Women with Traumatic Fractures
June 9th 2021An analysis of data from the Women's Health Initiative provides an overview of the risk of subsequent fracture seen among women with a history of traumatic versus nontraumatic fracture in postmenopausal women.
Read More
Study Underlines Importance of Quality Sleep in Patients with Diabetes
June 8th 2021An analysis of data from nearly 500k patients suggests patients with diabetes experiencing frequent insomnia were at an 87% increased risk of all-cause mortality compared to those with neither sleep disturbances nor diabetes.
Read More
Survey Suggests Nearly 50% of Cardiologists Report Having a Hostile Work Environment
June 7th 2021An analysis of survey data from cardiologists in multiple regions throughout the world portrays a field in need of reform, with more than 4-in-10 reporting a hostile work environment and some form of discrimination reported by 3-in-10 cardiologists.
Read More
Study Suggests 2 Servings of Fruit Per Day Cuts Odds of Developing Diabetes by 36%
June 6th 2021An analysis of food frequency questionnaire and biomarker data from more than 7000 adults indicates consumption of 2 or more servings of whole fruit per day was associated with 36% lower odds of developing diabetes in the next half-decade.
Read More
Semaglutide (Wegovy) Approved for Chronic Weight Management in Patients with Obesity or Overweight
June 4th 2021The FDA has announced the approval of semaglutide 2.4 mg (Wegovy) for chronic weight management in patients with obesity or overweight—the first drug to receive such an approval from the FDA in more than half a decade.
Read More
Medtronic Halts Sale of HVAD System, FDA Issues Warning to Stop New Implants
June 4th 2021After receiving more than 100 complaints, including some involving death, Medtronic has halted sale of the HeartWare Ventricular Assist Device System and the FDA has issued a warning to clinicians to stop new implants of the device.
Read More
Real-Time CGM Use Reduces HbA1c, Outpatient Visits in Patients with Type 1 and Type 2 Diabetes
June 3rd 2021A retrospective look at patients who initated real-time CGM versus noninitiators indicates CGM use resulted in significant reductions in HbA1c and also reduced the number of outpatient and telephone visits among patients with type 1 diabetes and type 2 diabetes.
Read More
Pair of Trials Demonstrate Reveal LINQ's Ability to Improve Detection of Atrial Fibrillation
June 3rd 2021Simultaneously published in JAMA, the PER DIEM and STROKE-AF trials demonstrate the ability of Medtronic's insertable cardiac monitor, Reveal LlNQ, to improve detection of atrial fibrillation in patients with a history of stroke.
Read More
Meta-Analysis Details CVD Risk After Thyroidectomy in Patients with Thyroid Cancer
June 3rd 2021Data from AACE 2021 suggests the risk of cardiovascular disease was 15% greater among patients with thyroid cancer who underwent thyroidectomy than the general population, but found no significant difference in risk of cardiac mortality and atrial fibrillation.
Read More
Age, Disease History Play Role in Developing Peripheral Artery Disease in Patients with Diabetes
June 1st 2021A systematic review and meta-analysis presented at AACE 2021 shed light on risk factors associated with increased odds of developing peripheral artery disease among patients with type 2 diabetes.
Read More
Starting CGM Use at Hospital Discharge Did Not Reduce Readmission Risk in Type 2 Diabetes Patients
May 30th 2021Despite the investigators' hypothesis, implementing use of CGM at hospital discharge did not reduce risk of emergency department visits or rehospitalizations among patients with uncontrolled type 2 diabetes.
Read More
A retrospective analysis of EHR data suggests use of CGM or visits from a diabetes educator or nutritionist were associated with a decrease in gaps between receiving care at a pediatric endocrinology clinic and an adult clinic among patients transitioning from pediatric to adult diabetes.
Read More
More Gradual Dose Titration Could Reduce Hypocortisolism Risk with Osilodrostat in Cushing's Disease
May 28th 2021Data from LINC3 and LINC4 provide insight into the impact of dosing titration schedules on risk of hypocortisolism-related adverse events associated with osilodrostat use in patients with Cushing's disease.
Read More
Women Who Experience Premature Menopause at Increased Risk of Coronary Heart Disease
May 27th 2021An analysis of data from 10k women in the Lifetime Risk Pooling Project presented at EPI Lifestyle 2021 suggests premature menopause was associated with a 40% increase in risk of coronary heart disease.
Read More
AACE 2021 Study Details SGLT2 Inhibitor Trends in US Diabetes Center
May 27th 2021Data from a retrospective review of patients with type 2 diabetes and heart failure at a diabetes center in Maryland details trends in prescribing and discontinuation in a real-world setting over a 5-year period.
Read More
Analysis Demonstrates MiniMed 670G System Helps Improve A1c and Time in Range in Type 1 Diabetes
May 27th 2021A systematic review and meta-analysis of a dozen trials assessing the MiniMed 670G system provides insight into the effects of the hybrid closed-loop system on A1c and time in range among patients with type 1 diabetes.
Read More